IRCT2015071323184N1 IRCT 2015-08-08 Arak University of Medical Sciences The effect of atorvastatin on patients with multiple sclerosis The effect of atorvastatin on the disease process in patients with multiple sclerosis 2011-03-20 anticipated 60 Complete https://irct.ir/trial/19821 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention. 2-3 Multiple Sclerosis. Intervention 1: The control group: There was no intervention and patients had received the routine treatment. The routine treatment was prescribed due to the doctor's viewpoint and based on disease symptoms and the patient's needs and included drugs such as CinnoVex, Betaferon, Baclofen, Amantadine, etc. Intervention 2: The Case group: In case group, patients in addition to routine therapy were treated with oral Atorvastatin 80 mg daily for one year.